ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Broad and Deerfield form lucrative pact

by Lisa M. Jarvis
October 16, 2017 | APPEARED IN VOLUME 95, ISSUE 41

In a unique partnership, the health care venture firm Deerfield Management will invest more than $50 million in drug discovery projects at Broad Institute of MIT & Harvard. During the five-year pact, Deerfield will support academic research—initially five to 10 projects—and have an option to create companies based on promising programs. While a number of research institutions have hooked up with drug companies that want to gain early access to academic discoveries, Broad’s pact with an investment firm is unusual.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment